Literature DB >> 3103118

A clinically effective breast cancer screening program can be cost-effective, too.

A P Carter, R S Thompson, R V Bourdeau, J Andenes, H Mustin, H Straley.   

Abstract

The logistics of complying with current American Cancer Society breast cancer screening recommendations in a large health maintenance organization, serving more than 50,000 women age 40 or older, are described. An alternative screening approach estimated to be at least as health-effective as the American Cancer Society recommendations has been developed and appears to solve the problem and is financially feasible. Cost-effectiveness depends on optimal use of mammography and health-care personnel resources. The authors show how the start-up and maintenance costs of an organized program can be offset by future cost savings resulting from reduced long-term disability in patients diagnosed at Stages 0-1 as opposed to Stages 2 and later. Careful selection of the delivery model before implementation can make a breast cancer screening program cost-effective as well as health-effective.

Entities:  

Mesh:

Year:  1987        PMID: 3103118     DOI: 10.1016/0091-7435(87)90003-x

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  11 in total

1.  Breast cancer risk and participation in mammographic screening.

Authors:  S Taplin; C Anderman; L Grothaus
Journal:  Am J Public Health       Date:  1989-11       Impact factor: 9.308

2.  Current realities of delivering mammography services in the community: do challenges with staffing and scheduling exist?

Authors:  Carl D'Orsi; Shin-Ping Tu; Connie Nakano; Patricia A Carney; Linn A Abraham; Stephen H Taplin; R Edward Hendrick; Gary R Cutter; Eric Berns; William E Barlow; Joann G Elmore
Journal:  Radiology       Date:  2005-03-29       Impact factor: 11.105

3.  Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography.

Authors:  Joann G Elmore; Stephen H Taplin; William E Barlow; Gary R Cutter; Carl J D'Orsi; R Edward Hendrick; Linn A Abraham; Jessica S Fosse; Patricia A Carney
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

Review 4.  Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.

Authors:  H M Bryson; G L Plosker
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

5.  Mammographers' perception of women's breast cancer risk.

Authors:  Joseph R Egger; Gary R Cutter; Patricia A Carney; Stephen H Taplin; William E Barlow; R Edward Hendrick; Carl J D'Orsi; Jessica S Fosse; Linn Abraham; Joann G Elmore
Journal:  Med Decis Making       Date:  2005 May-Jun       Impact factor: 2.583

6.  Assessing prevention effectiveness using data to drive program decisions.

Authors:  S B Thacker; J P Koplan; W R Taylor; A R Hinman; M F Katz; W L Roper
Journal:  Public Health Rep       Date:  1994 Mar-Apr       Impact factor: 2.792

7.  Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters.

Authors:  Diana S M Buist; Hongyuan Gao; Melissa L Anderson; Tracy Onega; Susan Brandzel; Melissa A Rabelhofer; Susan Carol Bradford; Erin J Aiello Bowles
Journal:  Prev Med       Date:  2017-06-24       Impact factor: 4.018

8.  The role of computers in preventive medicine in a rural family practice.

Authors:  W Hogg
Journal:  CMAJ       Date:  1990-07-01       Impact factor: 8.262

9.  Using physician correspondence and postcard reminders to promote mammography use.

Authors:  S H Taplin; C Anderman; L Grothaus; S Curry; D Montano
Journal:  Am J Public Health       Date:  1994-04       Impact factor: 9.308

10.  The danger of applying uniform clinical policies across populations: the case of breast cancer in American Indians.

Authors:  P A Nutting; B N Calonge; D C Iverson; L A Green
Journal:  Am J Public Health       Date:  1994-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.